Patents by Inventor Anat IOSUB-AMIR

Anat IOSUB-AMIR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANNABIGEROLIC ACID (CDGA) DERIVATIVES AND USES THEREOF
    Publication number: 20230202964
    Abstract: The present invention provides novel compounds comprising cannabigerolic acid (CBGA) derivatives, including acids and esters, and uses thereof in the treatment of various diseases, disorders, conditions and symptoms.
    Type: Application
    Filed: June 3, 2021
    Publication date: June 29, 2023
    Inventors: Reshef Swisa, Anat Iosub-Amir, Ron Harabani, Raphael Mechoulam, Natalya M. Kogan
  • CANNABIDIOLIC ACID (CBDA) DERIVATIVES AND USES THEREOF
    Publication number: 20230192588
    Abstract: The present invention provides novel compounds comprising cannabidiolic acid (CBDA) derivatives, including acids and esters, and uses thereof in the treatment of various diseases, disorders, conditions and symptoms.
    Type: Application
    Filed: June 3, 2021
    Publication date: June 22, 2023
    Inventors: Reshef Swisa, Anat Iosub-Amir, Ron Harabani, Raphael Mechoulam, Natalya M. Kogan
  • NAF-1 derived peptides and uses thereof
    Patent number: 11208443
    Abstract: The present invention provides peptides comprising a sequence derived from the human NAF-1 protein, analogs of said sequence or a retro-inverso sequence of said peptide or analog. The conjugates of such peptides are provided as well. The peptides and the conjugates of the present invention are useful in treating cancer, and in particular cancer in which the expression of NAF-1 is enhanced.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: December 28, 2021
    Assignee: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
    Inventors: Rachel Nechushtai, Assaf Friedler, Anat Iosub-Amir, Merav Darash-Yahana, Yang-Sung Sohn, Dorit Michaeli
  • NAF-1 DERIVED PEPTIDES AND USES THEREOF
    Publication number: 20190375805
    Abstract: The present invention provides peptides comprising a sequence derived from the human NAF-1 protein, analogs of said sequence or a retro-inverso sequence of said peptide or analog. The conjugates of such peptides are provided as well. The peptides and the conjugates of the present invention are useful in treating cancer, and in particular cancer in which the expression of NAF-1 is enhanced.
    Type: Application
    Filed: February 12, 2018
    Publication date: December 12, 2019
    Inventors: Rachel NECHUSHTAI, Assaf FRIEDLER, Anat IOSUB-AMIR, Merav DARASH-YA-HANA, Yang-Sung SOHN, Dorit MICHAELI